Press What’s news at AbelsonTaylor Group
Select category
Agency 100 Studio Session: AbelsonTaylor | The future of generative AI in pharma marketing
AT’s VP – Director of Engagement Strategy Sharlene Jenner discusses some of the opportunities and challenges generative AI will bring in the future of pharma marketing. Through this podcast, Sharlene discusses how marketers must bring their teams together to maximize the new technology, while also trying to gain a better understanding of privacy laws, and intellectual property protection.
Read more at MM+M Online.
Media Contact:
Recent Posts
Elise Pietracatella Joins AbelsonTaylor Group as Planning Director
AbelsonTaylor Group today announced that Elise Pietracatella has joined the agency as Planning Director. A seasoned strategy leader with more...
Read Press Read more Elise Pietracatella Joins AbelsonTaylor Group as Planning DirectorIndependence, Innovation, and Momentum: AbelsonTaylor Group’s Defining Moment
AbelsonTaylor Group is having a moment. In a recent Med Ad News profile, the agency is recognized for a year...
In the News Read more Independence, Innovation, and Momentum: AbelsonTaylor Group’s Defining MomentTerence Prudhomme of AT Activate Named 2026 Agency Vanguard Award Winner
AbelsonTaylor Group today announced that Terence Prudhomme, VP, Media Strategy at AT Activate, the agency’s full-service media strategy and buying...
Read Press Read more Terence Prudhomme of AT Activate Named 2026 Agency Vanguard Award WinnerConnect with us
Find out what's top of mind for the people reimagining health and wellness advertising.